Moreover, in a different study, Lakshmanan et al. presented findings that indicated that the mucin 16 (MUC16)/Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3)/GR signaling axis promotes NSCLC. Here, JAK2 is linked to non-small cell lung carcinoma.